1Ruf RG, Schultheiss M. Prevalence of WTI mutations in a large cohort of patients with steroid - resistant and steroid - sensitive nephrotic syndrome [J]. Kidney Int,2004,66 (2) :564 -570.
2Leung DY, Bloom JW. Update on glucocorticoid action and resistance [ J]. Allergy Clin Immunol,2003,111 (1) :3 -22.
3Hess J, Angel P, Sehorpp - Kistner M. AP - 1 subunits: quarrel and harmony among siblings [ J ]. J Cell Sci,2004,117 (25) :5965 - 5972.
5Nakajima M, Fujiki YI. Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1 [ J ]. J Clin Pharmacol,2005,45 (6) : 674 - 682.
9Ye J, Yu Z, Ding J, et al. Genetic variations of the NR3C1 gene in children with sporadic nephrotic syndrome [ J ]. Biochem Biophy Res Commun ,2006,348 (2) :507 - 513.
10Ruf RG, Liehtenberger A. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol, 2004,15:722 -732.
8Alles AE,Jordan MS.Nephrotic sydrome in childhood.Lancet,2003,362(23):629-639.
9Weigert C,Sauer U,Brodbeck K,et al.AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-betal promoter in mesangialcells.J Am Soc Nephrol,2000,11(11):2007-2016.
10Couser WG.Pathogenesis of glomerular damage in glomerulonephritis.Nephrol Dial Transplant,1998,13(Supp11):10-15.
